Milk of Magnesia Should Be Avoided in Patients with Kidney Disease
Milk of magnesia (magnesium hydroxide) is contraindicated in patients with kidney disease due to the high risk of life-threatening hypermagnesemia, particularly as kidney function declines. The FDA drug label explicitly warns to "ask a doctor before use if you have kidney disease" 1, and this warning exists for good reason—multiple fatal cases have been documented.
Why This Is Dangerous
Patients with CKD cannot adequately excrete magnesium through their kidneys. When magnesium-containing products like milk of magnesia are ingested:
- Severe hypermagnesemia develops rapidly, even with normal doses
- Life-threatening complications include cardiac arrest, severe bradycardia, asystole, respiratory failure, and hypothermia 2, 3
- A documented case showed a patient with end-stage renal disease developing magnesium levels >4.1 mmol/L (>10 mg/dL) after using milk of magnesia, resulting in cardiac arrest 2
- Another fatal case occurred in a patient taking 3,000 mg daily who developed a magnesium level of 11.0 mg/dL despite attempts at dialysis 3
The Evidence Against Use
Recent large-scale population data (2026) demonstrates clear harm: A nationwide cohort study of CKD patients showed magnesium oxide use was associated with dramatically increased risks 4:
- 37-fold increased risk of acute kidney injury (aHR = 37.0)
- 6.3-fold increased risk of acute kidney disease (aHR = 6.26)
- 3.1-fold increased risk of ESRD requiring dialysis (aHR = 3.13)
- 2.1-fold increased risk of cardiac arrhythmia (aHR = 2.06)
- 1.9-fold increased risk of acute myocardial infarction (aHR = 1.86)
The risk escalates with advancing CKD stage, with stages 4-5 showing the highest hazards 4.
Clinical Guideline Perspective
The 2024 KDIGO guidelines emphasize that clinicians should "review and limit the use of over-the-counter medicines and dietary or herbal remedies that may be harmful for people with CKD" 5. Milk of magnesia falls squarely into this category. The guidelines also stress that "people with CKD may be more susceptible to the nephrotoxic effects of medications" and to "always consider the benefits versus potential harms" 5.
What About Controlled Magnesium Supplementation?
While the 2025 KDIGO controversies conference noted that magnesium-based interventions showed contradictory results for vascular calcification 6, and some studies suggest potential benefits of carefully monitored magnesium supplementation 7, 8, 9, this is fundamentally different from over-the-counter milk of magnesia use:
- Clinical trials used controlled dosing with intensive monitoring
- One study in hemodialysis patients kept serum magnesium <4.5 mEq/L with doses of 0.75-3 g/day under close supervision 10
- Gastrointestinal adverse effects limit adherence even in monitored settings 6
Critical Pitfalls to Avoid
- Do not assume "natural" or over-the-counter means safe in CKD patients
- Hypermagnesemia can mimic acute coronary syndrome or septic shock, leading to delayed diagnosis 2
- Even patients with normal kidney function have developed fatal hypermagnesemia from milk of magnesia 3
- The risk is dose-dependent and cumulative 4
Practical Recommendation
For constipation in CKD patients, use alternative laxatives that do not contain magnesium. Options include:
- Polyethylene glycol (PEG) solutions
- Docusate sodium
- Senna-based products
- Lactulose
If magnesium supplementation is genuinely needed for other medical reasons (e.g., documented hypomagnesemia), this should only occur under nephrologist supervision with regular serum magnesium monitoring, and never using over-the-counter milk of magnesia.